Back to trial details

Intake questionnaire

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Applying to Atlanta Gastroenterology Associates · Atlanta, Georgia

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 16 and 80 years old?
2. Have you been diagnosed with Moderately to Severely Active Crohns Disease?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Atlanta for study visits?